Answer
Invega (paliperidone) prolonged-release tablets are contraindicated in people with hypersensitivity to paliperidone, risperidone, or any excipient listed in section 6.1 of the product information.
Sources for this answer
- Invega 3 mg prolonged-release tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked